| Reusable insulin pen to lead Biocon's new launches - Hindu Business Line |
|
|
Hindu Business Line The portfolio has grown to around 36 products or versions for diabetes, nephrology, cancer treatment, cardio-vascular problems and immuno-dermatology. Each therapy is a division. Branded products grew at an average rate of 36 per cent during 2010-11 |